Heterocyclic alkylphospholipids with an improved therapeutic range.
暂无分享,去创建一个
T. Klenner | J. Engel | P. Hilgard | B. Kutscher | J. Stekar | G. Nössner
[1] J. Verweij,et al. Phase II study of oral miltefosine in patients with squamous cell head and neck cancer. , 1993, European journal of cancer.